Short-Term Androgen Deprivation Therapy and High-Dose Radiotherapy in Intermediate- and High-Risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase III Trial

Autor: Demogeot, N., Sargos, P., Sahki, N., Guerif, S., De Crevoisier, R., Calais, G., Hannoun-Levi, J.M., Bouché, G., Hennequin, C., Cretin, J., Belkacemi, Y., Khalifa, J., Azria, D., Bauer, N., Pommier, P., Simon, J.M., Léger, C., Beckendorf, V., Dubray, B.M., Supiot, S.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 October 2024 120(2) Supplement:S4-S5
Databáze: ScienceDirect